Benztropine Mesylate

Generic name

Benztropine Mesylate

Covered by Medicare


Get a Medicare Quote

Average Annual Cost per Beneficiary


Average cost per year*

Average Annual Cost per Dose



Average cost per beneficiary*


  • Zydus Pharmaceu
  • West-Ward/Hikma
  • Upsher Smith La
  • Qualitest/Par P
  • Marlex Pharm.
  • Major Pharmaceu
  • Excellium Pharm
  • Cipla USA, Inc.
  • Chartwell Rx Ll
  • Bayshore Pharma
  • Leading Pharma
  • App/Fresenius K
  • AHP

What is Benztropine Mesylate

Benztropine is used to treat symptoms of Parkinson's disease or involuntary movements due to the side effects of certain psychiatric drugs (antipsychotics such as chlorpromazine/haloperidol). Benztropine belongs to a class of medication called anticholinergics that work by blocking a certain natural substance (acetylcholine). This helps decrease muscle stiffness, sweating, and the production of saliva, and helps improve walking ability in people with Parkinson's disease. Anticholinergics can stop severe muscle spasms of the back, neck, and eyes that are sometimes caused by psychiatric drugs. It can also decrease other side effects such as muscle stiffness/rigidity (extrapyramidal signs-EPS). It is not helpful in treating movement problems caused by tardive dyskinesia and may worsen them. Benztropine should not be used by children younger than 3 years. NOTE: This is a summary and does NOT have all possible information about this product. This information does not assure that this product is safe, effective, or appropriate for you. This information is not individual medical advice and does not substitute for the advice of your health care professional. Always ask your health care professional for complete information about this product and your specific health needs.

Drug Trends

*Origin of the terms and chart data used within this page:

Common Questions About Benztropine Mesylate

Yes, Benztropine Mesylate is covered by Medicare.

In 2021, the average cost per dose of Benztropine Mesylate was $0.25.

The average dose of Benztropine Mesylate received per year is 123,756,720 units

274,423 Medicare beneficiaries received Benztropine Mesylate in 2021, which was a -0.02% from 2020

There were 2,130,642 claims made by Medicare beneficiaries, which is a -0.03% from 2020

The average spending amount per claim in 2021 was $13.43

The average Medicare spending per beneficiary amount for Benztropine Mesylate was $104.24

The most expensive manufacturer of Benztropine Mesylate is West-Ward/Hikma

Marlex Pharm. is the least expensive manufacturer with an Average Spending Per Dosage Unit of $0.16

Leading Pharma received $14,876,422.95

The total amount spent on Benztropine Mesylate by Medicare is $28,605,139.22

© 2021-2024, LLC

Privacy Policy  |  Terms and Conditions

GENERAL DISCLAIMERS is a commercial site designed for the solicitation of insurance from selected health insurance carriers and, LLC is a licensed insurance agency. It is not a government agency. It is also not an insurer, or a medical provider., LLC is a licensed representative of Medicare Advantage (HMO, PPO, PFFS, and PDP) organizations that have a Medicare contract. Enrollment depends on the plan’s contract renewal.
We do not offer every plan available in your area. Currently we represent nine carrier plan organizations nationally. Please contact, 1-800-MEDICARE, or your local State Health Insurance Program (SHIP) to get information on all of your options.
Alternatively, you may be referred, via a link, to a selected partner website, which is independently owned and operated and may have different privacy and terms of use policies from us.
If you provide your contact information to us, an insurance agent/producer or insurance company may contact you. If you do not speak English, language assistance service, free of charge, is available to you; contact the toll-free number listed above. This site is not maintained by or affiliated with the federal government's Health Insurance Marketplace website or any state government health insurance marketplace.
The plans we represent do not discriminate on the basis of race, color, national origin, age, disability, or sex. To learn more about a plan's nondiscrimination policy, please click here.
Not all plans offer all of these benefits. Benefits may vary by carrier and location. Limitations and exclusions may apply.